VMS BioMarketing Names Tom Fagan as Chief Operating Officer
VMS BioMarketing a leading provider of nurse-led patient and HCP engagement solutions for the biopharma industry – announced that Thomas D. Fagan, Jr. has joined the company as Chief Operating Officer.
“Tom joins us at a time when we are experiencing extensive growth in the company product offering, biopharma client base and patient and healthcare provider interactions, driven by increased demand from various healthcare constituents including life sciences, payors, providers and public health organizations,” said Andrea Heslin Smiley, President and CEO. “Tom’s prior experience positions him well to lead all aspects of VMS operations and the continued strategic investments in technology, people and infrastructure with the goal of furthering our mission to build real patient connections that lead to better health outcomes.”
Recommended AI News: Pax8 and LogMeIn Join Forces to Offer Partners LastPass Single Sign-On and Password Management Capabilities
On joining VMS, Fagan said, “The company’s leadership position in the industry, proven experience, singular focus on nursing and unparalleled solution offering is what excites me. I look forward to being a part of shaping the future of VMS and the lasting impact we can have on patient outcomes while delivering tremendous support to our client partners.”
Recommended AI News: Fast Simon Announces Integration of InstantSearch+ Using Microsoft Dynamics 365 Commerce
Fagan’s extensive experience includes global and U.S. leadership positions in product development, brand development, operations, commercialization, digital marketing, business development and alliance management across pharmaceutical, device and diagnostic businesses.
Most recently, Fagan served at Eli Lilly and Company as a marketing leader in its U.S. business supporting efforts to drive omni-channel customer engagement and digital marketing capabilities for promoted brands. He also served in leadership positions in the Alzheimer’s disease, chronic pain and osteoporosis therapeutic areas at Lilly and in the renal division and corporate business development department at Baxter International, Inc. He started his career in the investment banking division at Goldman, Sachs & Co.
Recommended AI News: Vigorate Digital Solutions Selects Pivotree for AWS Managed Services
Comments are closed.